Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis

scientific article published on 6 December 2016

Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JCPH.843
P698PubMed publication ID27922719

P50authorJessica E HabererQ57891949
Craig W HendrixQ59688777
David R BangsbergQ60227555
Jared M BaetenQ89443633
Michael J FosslerQ97535318
Ayyappa ChaturvedulaQ117266738
Connie CelumQ42571941
P2093author name stringMark Sale
Kumpal Madrasi
P2860cites workThe impact of patient compliance on drug concentration profile in multiple doses.Q52888493
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenQ24612082
Antiretroviral prophylaxis for HIV prevention in heterosexual men and womenQ28270788
Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infectionQ28481276
Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East AfricaQ28533158
Preexposure prophylaxis for HIV infection among African womenQ29620077
Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence StudyQ30944686
A new taxonomy for describing and defining adherence to medicationsQ31054192
Modelling overdispersion and Markovian features in count dataQ33508253
An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in UgandaQ34314648
Patient adherence to treatment: three decades of research. A comprehensive reviewQ34419183
How often is medication taken as prescribed? A novel assessment techniqueQ34525872
Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementationQ34606560
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigmQ35780443
Clinical trial simulation: a tool for understanding study failures and preventing themQ36055589
Emtricitabine: a novel nucleoside reverse transcriptase inhibitorQ36202241
Diagnosing model diagnosticsQ36850144
Estimation of tenofovir's population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategiesQ37210864
Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissueQ37258298
Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing historiesQ37937669
Transition modeling of neuropsychiatric impairment in HIV.Q38854880
Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East AfricaQ38856099
Markov model for characterizing neuropsychologic impairment and Monte Carlo simulation for optimizing efavirenz therapy.Q38859179
A Markov mixed effect regression model for drug complianceQ40834986
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.Q41730905
Modelling a spontaneously reported side effect by use of a Markov mixed-effects modelQ42673308
A dynamic model of hand-and-foot syndrome in patients receiving capecitabineQ44014861
Methods for measuring, enhancing, and accounting for medication adherence in clinical trials.Q46630774
Exposure-response analysis for spontaneously reported dizziness in pregabalin-treated patient with generalized anxiety disorderQ46769733
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleepQ48714607
Time to stop counting the tablets?Q52876428
P433issue5
P921main subjectcovariateQ5178903
P304page(s)606-615
P577publication date2016-12-06
P1433published inThe Journal of Clinical PharmacologyQ7743562
P1476titleMarkov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis
P478volume57

Reverse relations

Q92238024Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approachcites workP2860